Arq Bras Endocrinol Metab 2007;51(3):504-505
Cross-reactivity of new insulin analogs in insulin assays
DOI: 10.1590/S0004-27302007000300022
Flow diagram of patient exclusion criteria for SNMTC and FNMTC groups.
Vieira JGH, Tachibana TT, Ferrer CM, Reis AF. Cross-reactivity of new insulin analogs in insulin assays. Arq Bras Endocrinol Metab 2007;51(3):504-5.
Vieira, José Gilberto H.; Tachibana, Teresinha T.; Ferrer, Cláudia M.; Reis, André F.. Cross-reactivity of new insulin analogs in insulin assays. Arq Bras Endocrinol Metab, v. 51, n. 3, p. 504-505, Apr. 2007.
Vieira, J. G. H., Tachibana, T. T., Ferrer, C. M., & Reis, A. F. (2007). Cross-reactivity of new insulin analogs in insulin assays. Arq Bras Endocrinol Metab, 51(3), 504-505.
Vieira, José Gilberto H. and Tachibana, Teresinha T. and Ferrer, Cláudia M. and Reis, André F.. Cross-reactivity of new insulin analogs in insulin assays. Arq Bras Endocrinol Metab [online]. 2007, vol. 51, n. 3, [cited 2026-03-07], pp.504-505. Available from: <https://www.aem-sbem.com/article/cross-reactivity-of-new-insulin-analogs-in-insulin-assays/>. ISSN 2359-3997.